Literature DB >> 30664870

Tau Modulates VGluT1 Expression.

Giacomo Siano1, Martina Varisco1, Maria Claudia Caiazza1, Valentina Quercioli1, Marco Mainardi1, Chiara Ippolito2, Antonino Cattaneo1, Cristina Di Primio3.   

Abstract

Tau displacement from microtubules is the first step in the onset of tauopathies and is followed by toxic protein aggregation. However, other non-canonical functions of Tau might have a role in these pathologies. Here, we demonstrate that a small amount of Tau localizes in the nuclear compartment and accumulates in both the soluble and chromatin-bound fractions. We show that favoring Tau nuclear translocation and accumulation, by Tau overexpression or detachment from MTs, increases the expression of VGluT1, a disease-relevant gene directly involved in glutamatergic synaptic transmission. Remarkably, the P301L mutation, related to frontotemporal dementia FTDP-17, impairs this mechanism leading to a loss of function. Altogether, our results provide the demonstration of a direct physiological role of Tau on gene expression. Alterations of this mechanism may be at the basis of the onset of neurodegeneration.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Tau; Tau P301L; VGluT1; gene expression; nuclear tau

Mesh:

Substances:

Year:  2019        PMID: 30664870     DOI: 10.1016/j.jmb.2019.01.023

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  Extremely Low Forces Induce Extreme Axon Growth.

Authors:  Sara De Vincentiis; Alessandro Falconieri; Marco Mainardi; Valentina Cappello; Vincenzo Scribano; Ranieri Bizzarri; Barbara Storti; Luciana Dente; Mario Costa; Vittoria Raffa
Journal:  J Neurosci       Date:  2020-05-22       Impact factor: 6.167

2.  KDM6B cooperates with Tau and regulates synaptic plasticity and cognition via inducing VGLUT1/2.

Authors:  Yanan Wang; Nitin Khandelwal; Shuiqiao Liu; Mi Zhou; Lei Bao; Jennifer E Wang; Ashwani Kumar; Chao Xing; Jay R Gibson; Yingfei Wang
Journal:  Mol Psychiatry       Date:  2022-08-26       Impact factor: 13.437

3.  Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.

Authors:  Evan Lester; Felicia K Ooi; Nadine Bakkar; Jacob Ayers; Amanda L Woerman; Joshua Wheeler; Robert Bowser; George A Carlson; Stanley B Prusiner; Roy Parker
Journal:  Neuron       Date:  2021-04-12       Impact factor: 17.173

4.  Tau affects P53 function and cell fate during the DNA damage response.

Authors:  Martina Sola; Claudia Magrin; Giona Pedrioli; Sandra Pinton; Agnese Salvadè; Stéphanie Papin; Paolo Paganetti
Journal:  Commun Biol       Date:  2020-05-19

5.  Identification of an ERK Inhibitor as a Therapeutic Drug Against Tau Aggregation in a New Cell-Based Assay.

Authors:  Giacomo Siano; Maria Claudia Caiazza; Ivana Ollà; Martina Varisco; Giuseppe Madaro; Valentina Quercioli; Mariantonietta Calvello; Antonino Cattaneo; Cristina Di Primio
Journal:  Front Cell Neurosci       Date:  2019-08-21       Impact factor: 5.505

Review 6.  Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease.

Authors:  Marta Fernández-Nogales; José J Lucas
Journal:  Front Cell Neurosci       Date:  2020-01-17       Impact factor: 5.505

7.  The Q336H MAPT Mutation Linked to Pick's Disease Leads to Increased Binding of Tau to the Microtubule Network via Altered Conformational and Phosphorylation Effects.

Authors:  Giacomo Siano; Mariachiara Micaelli; Arianna Scarlatti; Valentina Quercioli; Cristina Di Primio; Antonino Cattaneo
Journal:  Front Mol Neurosci       Date:  2020-12-02       Impact factor: 5.639

Review 8.  The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics.

Authors:  Sarah A Kent; Tara L Spires-Jones; Claire S Durrant
Journal:  Acta Neuropathol       Date:  2020-07-29       Impact factor: 15.887

Review 9.  Molecular, Structural, Functional, and Pharmacological Sites for Vesicular Glutamate Transporter Regulation.

Authors:  Nicolas Pietrancosta; Mahamadou Djibo; Stephanie Daumas; Salah El Mestikawy; Jeffrey D Erickson
Journal:  Mol Neurobiol       Date:  2020-05-30       Impact factor: 5.682

10.  Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer's Disease Progression.

Authors:  Laura Gil; Sandra A Niño; Erika Chi-Ahumada; Ildelfonso Rodríguez-Leyva; Carmen Guerrero; Ana Belén Rebolledo; José A Arias; María E Jiménez-Capdeville
Journal:  Int J Mol Sci       Date:  2020-03-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.